- Home
- ALAR vs MNOV Comparison
ALAR vs MNOV Comparison
Compare ALAR & MNOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- MNOV
- Stock Information
- Founded
- ALAR 2013
- MNOV 2000
- Country
- ALAR Israel
- MNOV United States
- Employees
- ALAR N/A
- MNOV N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- MNOV Biotechnology: Pharmaceutical Preparations
- Sector
- ALAR Technology
- MNOV Health Care
- Exchange
- ALAR Nasdaq
- MNOV Nasdaq
- Market Cap
- ALAR 45.3M
- MNOV 68.2M
- IPO Year
- ALAR 2018
- MNOV 2005
- Fundamental
- Price
- ALAR $13.89
- MNOV $1.25
- Analyst Decision
- ALAR Strong Buy
- MNOV Strong Buy
- Analyst Count
- ALAR 1
- MNOV 2
- Target Price
- ALAR $15.00
- MNOV $7.00
- AVG Volume (30 Days)
- ALAR 261.4K
- MNOV 14.8K
- Earning Date
- ALAR 08-25-2025
- MNOV 08-07-2025
- Dividend Yield
- ALAR N/A
- MNOV N/A
- EPS Growth
- ALAR N/A
- MNOV N/A
- EPS
- ALAR 0.07
- MNOV N/A
- Revenue
- ALAR $30,581,000.00
- MNOV N/A
- Revenue This Year
- ALAR N/A
- MNOV N/A
- Revenue Next Year
- ALAR $12.28
- MNOV N/A
- P/E Ratio
- ALAR $20.74
- MNOV N/A
- Revenue Growth
- ALAR 4.67
- MNOV N/A
- 52 Week Low
- ALAR $5.45
- MNOV $1.12
- 52 Week High
- ALAR $46.69
- MNOV $2.55
- Technical
- Relative Strength Index (RSI)
- ALAR 70.36
- MNOV 36.85
- Support Level
- ALAR $12.76
- MNOV $1.32
- Resistance Level
- ALAR $13.65
- MNOV $1.38
- Average True Range (ATR)
- ALAR 0.93
- MNOV 0.05
- MACD
- ALAR 0.07
- MNOV -0.00
- Stochastic Oscillator
- ALAR 86.68
- MNOV 0.00
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company. The company acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs with a specific focus on the U.S. market. Its products portfolio includes therapeutics such as MN-001, MN-166, MN-221 etc. The firm's current strategy is to focus its development activities on therapeutics for neurological disorders and fibrotic diseases.